CSF and plasma GABA levels in Parkinson's disease
Open Access
- 1 March 1982
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 45 (3) , 253-256
- https://doi.org/10.1136/jnnp.45.3.253
Abstract
CSF gamma-aminobutyric acid (GABA) levels were reduced in patients with idiopathic Parkinson's disease when compared with age matched controls, but the difference was not significant. However, when the Parkinsonian patients were subdivided, CSF GABA levels were lower in the levodopa treated group than in the untreated group and the controls. There was no difference in plasma GABA levels between Parkinsonian patients and controls.This publication has 10 references indexed in Scilit:
- Low CSF GABA in parkinsonian patients who respond poorly to therapy or suffer from the “on‐off” phenomenonAnnals of Neurology, 1982
- Biochemical alterations of dopamine receptor responses following chronic l-dopa therapyBiochemical Pharmacology, 1980
- Stability of GABA levels in CSF under various conditions of storageBrain Research, 1980
- The relationship between GABA concentrations in brain and cerebrospinal fluidBrain Research, 1979
- Sodium valproate in the treatment of levodopa-induced dyskinesia.Journal of Neurology, Neurosurgery & Psychiatry, 1978
- Baclofen in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1978
- Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid ([3H]GABA) binding in the human brain: Alterations in Parkinson's diseaseBrain Research, 1977
- Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disordersNeurology, 1976
- Glutamic acid decarboxylase in Parkinson's disease and epilepsyNeurology, 1971
- Monosynaptic inhibition of neurons of the substantia nigra by caudatonigral fibersBrain Research, 1971